Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Doctor Group Warns Of Kala Azar Spread In India, Southeast Asia

This article was originally published in PharmAsia News

Executive Summary

An official of Medecins Sans Frontieres warned Southeast Asian governments they need to make drugs more accessible to the poor as visceral leishmaniasis spreads and becomes treatment-resistant. The international group's tropical medical adviser said the disease, transmitted by sand flies, has an effective treatment in Ambisome (liposomal amphotericin B), shown to be 98 percent effective so far. But, she said, it and other drugs to fight the disease are not available to the people who need them most. At a conference in India where the potentially fatal disease is endemic, she called for it to be included in India's treatment protocol as a first-line option. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070975

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel